Gavi instituted injection safety support as one of its windows of support in 2000: a one-off, three-year grant was made available to all Gavi-eligible countries
Use of AD syringes higher in GAVI INS supported countries
Source: JSI Research & Training Institute, January 2009
Gavi began offering injection safety support (INS) in mid-2001 to countries that wanted to introduce or increase the use of auto-disable (AD) syringes and safety boxes into their national immunisation programmes for vaccines not supported by Gavi.
In addition, all Gavi supported vaccines are delivered with AD and safety boxes.
To encourage countries to find their own sustainable funding sources for injection safety, Gavi provided approved countries with sufficient AD syringes and safety boxes to immunise children and women for a period of three years only.
Initially, INS support was offered only to countries receiving immunisation services support (ISS), but eligibility was soon broadened to include all Gavi-eligible countries.
Map of countries approved for Gavi's injection safety support
In addition to INS in the form of commodities, Gavi offered cash as an alternative form of support to countries where AD syringes and safety boxes were already being ordered.
Instead of actual AD syringes and safety boxes, national immunisation programmes in these countries received funding equivalent to the cost (at prices obtained by UNICEF) of purchasing the materials for three years. This helped countries reinforce their training and monitoring and evaluation activity related to injection safety.